Kelix Bio Limited
Project disclaimer
Description
Kelix Bio (formerly Zanzibar Pharma) is a specialty generic pharmaceuticals business focused on emerging markets. The company aims to develop and commercialise affordable products in countries historically deprived of access to such medications.
Other
Direct Equity
Location
The country, countries or regions that benefit from this Programme.
Status Implementation
The current stage of the Programme, consistent with the International Aid Transparency Initiative's (IATI) classifications.
Programme Spend
Programme budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised.
Participating Organisation(s)
Help with participating organisations
Sectors
Sector groups as a percentage of total Programme budget according to the OECD Development Assistance Committee (DAC) classifications.
Budget
A comparison across financial years of forecast budget and spend to date on the Programme.